<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Crown Bioscience is a Contract Research Organization (CRO) specializing in oncology and immuno-oncology drug discovery and development. Our preclinical and translational services offer biotech and pharmaceutical companies the opportunity to remove the guesswork from their research and development. We are driven by our mission to empower our customers to improve human health across the globe. To do this, we engage the finest scientific talent, uphold the highest quality standards, and relentlessly pursue innovation.

Our Innovative Solutions

 
Explore 3D Bone Marrow Models

Explore 3D Bone Marrow Models

 
Advance Your <br>ADC

Advance Your
ADC

 
Discover Translational Biomarkers

Discover Translational Biomarkers

 
Progress Your <br>IO Molecule

Progress Your
IO Molecule

 
Integrate Mouse Clinical Trials

Integrate Mouse Clinical Trials

FDA Modernization Act 2.0

In 2022, the FDA Modernization Act 2.0 removed the mandate for animal testing in drug development. This year the FDA announced plans to phase out animal testing requirements for monoclonal antibodies and other therapies - shifting the focus toward more effective, human-relevant methods and embracing the 3Rs of animal research.

Read our Q&A on this topic

Industry-leading Customer Experience

The data presented below represents Q4 2024

Studies Completed

845 Studies Completed

This data point indicates the total number of studies in Q2 2024 that the CSAT, Customer Effort, and Customer Expectation scores are measured against.

Customer Satisfaction

96% Customer Satisfaction

Also known as CSAT, this metric indicates how satisfied customers are with the complete Crown Bioscience customer experience.

Customer Satisfaction Report

Industry-leading Customer Experience

Customer Effort

98% Customer Effort

The Customer Effort Score (CES) is a metric that measures how easy it was to work with Crown Bioscience.

Customer Expectation

100% Customer Expectation

This metric indicates the strength of Crown Bioscience in meeting or exceeding customer expectations.

Customer Satisfaction Report

Industry-leading Customer Experience

Latest Models
PARP Inhibitor Resistant PDX Model

OV4502: Acquired resistance to two PARP inhibitors

PREtreated Breast Cancer PDX Model

BR9801: Generated following patient treatment with sacituzumab govitecan (anti-Trop2 ADC)
KRAS-Resistant Cell Line

MIA PaCa-2-hKRAS-Y96D: CRISPR/Cas9 engineered second site KRAS mutations in cells harboring KRASG12C mutation

UNIQUE Organoid Kidney Model

KI11409B: Evaluate your renal-targeting therapies in our new organoid kidney model

View Our Resources

View Our

Resources

Free white papers, factsheets, on-demand webinars and more

Explore Our Tools

Read Our Publications

Read Our

Publications

Peer-reviewed papers highlighting our greatest R&D

Learn Something New

Explore Our Explore Our

Explore Our

Posters

Exciting updates and data from our world-class scientists

Discover The Data

Ensuring that every patient gets the right
treatment at the right time.